Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain

Journal of Neurochemistry

Volumn 77, Issue 4, 2001, Pages 1067-1076

  Jurevics, Helga ^a   Hostettler, Janell ^a   Muse, Evan D ^a   Sammond, Deanne W ^a   Matsushima, Glenn K ^b   Toews, Arrel D ^c   Morell, Pierre ^c  

^a The Neuroscience Center   (United States)

^b Department of Microbiology and Immunology ^*  (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Ceramide galactosyl transferase; Cholesterol; Myelin; Myelin basic protein

Indexed keywords

CEREBROSIDE; CHOLESTEROL; COPPER; CUPRIZONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYELIN; MYELIN BASIC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DEMYELINATION; DIET; LIPOGENESIS; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION; STEADY STATE;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; BRAIN STEM; CEREBELLUM; CEREBROSIDES; CHOLESTEROL; CUPRIZONE; GALACTOSYLTRANSFERASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYDROXYMETHYLGLUTARYL COA REDUCTASES; MALE; MICE; MICE, INBRED C57BL; MYELIN BASIC PROTEINS; MYELIN SHEATH; N-ACYLSPHINGOSINE GALACTOSYLTRANSFERASE; TIME FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 0034996380     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00310.x     Document Type: Article

References (45)

1. 14C-labeled substrates. J. Lipid Res. 20, 740-752.
2. Bednarczuk T., Wiggins A. R. C. and Konat G. W. (1991) Generation of high efficiency, single-stranded DNA hybridization probes by PCR. Biotechniques 10, 478.
3. Belknap W. M. and Dietschy J. M. (1988) Sterol synthesis and low density lipoprotein clearance in vivo in the pregnant rat, placenta, and fetus. Sources for tissue cholesterol during fetal development. J. Clin. Invest. 82, 2077-2085.
4. Benjamins J. A., Miller S. L. and Morell P. (1976) Metabolic relationships between myelin subfractions: entry of galactolipids and phospholipids. J. Neurochem. 27, 565-570.
5. Björkhem I., Lütjohann D., Breuer O., Sakinis A. and Wennmalm Å. (1997) Importance of a novel oxidative mechanism for elimination of brain cholesterol. J. Biol. Chem. 272, 30178-30184.
6. Blakemore W. F. (1973a) Demyelination of the superior cerebellar peduncle in the mouse induced by Cuprizone. J. Neurol. Sci. 20, 63-72.
7. Blakemore W. F. (1973b) Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding Cuprizone. J. Neurol. Sci. 20, 73-83.
8. Blakemore W. F. (1984) The response of oligodendrocytes to chemical injury. Acta Neurol. Scand. Suppl. 100, 33-38.
9. Carey E. M. and Freeman N. M. (1983) Biochemical changes in cuprizone-induced spongiform encephalopathy. I. Changes in the activities of 2′,3′-cyclic nucleotide 3′-phosphohydrolase, oligodendroglial ceramide galactosyl transferase, and the hydrolysis of the alkenyl group of alkenyl, acyl-glycerophospholipids by plasmalogenase in different regions of the brain. Neurochem. Res. 8, 1029-1044.
10. Chirgwin J. M., Przybyla A. E., MacDonald R. J. and Rutter W. J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
11. Day R., Gebhard R. L., Schwarts H. L., Strait K. A., Duane W. C., Stone B. G. and Oppenheimer J. H. (1989) Time course of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and messenger ribonucleic acid, biliary lipid secretion, and hepatic cholesterol content in methimazole-treated hypothyroid and hypophysecto-mized rats after triiodothyronine administration. Possible linkage of cholesterol synthesis to biliary secretion. Endocrinology 125, 459-468.
12. Dietschy J. M. and Spady D. K. (1984) Measurement of rates of cholesterol synthesis using tritiated water. J. Lipid Res. 25, 1469-1476.
13. Eto Y., Suzuki K. and Suzuki K. (1971) Lipid composition of rat brain myelin in triethyl tin-induced edema. J. Lipid Res. 12, 570-579.
14. Folch J., Lees M. and Sloane Stanley G. H. (1957) A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497-509.
15. Hadjiolov A. A., Georgiev O. I., Nosikov V. V. and Yavachev L. P. (1984) Primary and secondary structure of rat 28 S ribosomal RNA. Nucl. Acids Res. 12, 3677-3693.
16. Hiremath M. M., Saitl Y., Knapp G. W., Ting J. P.-Y., Suzuki K. and Matsushima G. K. (1998) Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J. Neuroimmunol. 92, 38-49.
17. Jansen R. and Ledley F. D. (1989) Production of high specific activity DNA probes using the polymerase chain reaction. Gene. Anal. Techn. 6, 79-83.
18. Jurevics H. and Morell P. (1994) Sources of cholesterol for kidney and nerve during development. J. Lipid Res. 35, 112-120.
19. Kagawa T., Oba A., Okumura S. and Ikenaka K. (1996) Localization of mRNA for UDP-galactose: ceramide galactosyltransferase in the brain during mouse development. Dev. Neurosci. 18, 309-318.
20. Knobler R. L., Rodriguez M., Lampert P. W. and Oldstone M. B. (1983) Virologie models of chronic relapsing demyelinating disease. Acta Neuropathol. (Berl.) 9 (Suppl.), 31-37.
21. Ludwin S. K. (1978) Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab. Invest. 39, 597-612.
22. Ludwin S. K. (1994) Central nervous system remyelination studies in chronically damaged tissue. Ann. Neurol. 36, 143-145.
23. Martin M., McFarland H. F. and McFarlin D. E. (1992) Immunological aspects of demyelinating diseases. Anna. Rev. Immunol. 10, 153-187.
24. Mason J. L., Jones J., Takiike M., Morell P., Suzuki K. and Matsushima G. K. (2000) Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelinaüon. J. Neurosci. Res. 61, 251-262.
25. Mason J. L., Langaman C. L., Morell P., Suzuki K. and Matsushima G.K. (2001) Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal caliber. Neuropathol. Appl. Neurobiol. in press.
26. Mathis C., Hindelang C., LeMeur M. and Borelli E. (2000) A transgenic mouse model for inducible and reversible dysmyelination. J. Neurosci. 20, 7698-7705.
27. Matsushima G. K. and Morell P. (2001) The neurotoxicant, Cuprizone, as a model to study demyelination and remyelination in the central nevous system. Brain Pathol. 11, 107-116.
28. Miller D. J., Asakura K. and Rodriguez M. (1996) Central nervous system remyelination: clinical application of basic neuroscience principles. Brain. Pathol. 6, 331-344.
29. Morell P. and Quarles R. H. (1999) Myelin formation, structure, and biochemistry, in Basic Neurochemistry, 6th edn (R. W. Albers, G. W. Siegel, P. Molinoff and B. Agranoff eds.), pp. 69-93. Raven Press, New York.
30. Morell P. and Toews A. D. (1997) Myelin and myelination as affected by toxicants, in Comprehensive Toxicology, Vol. 11: Nervous System and Behavioral Toxicology (Lowndes H.E. and Reuhl K.R. eds), pp. 201-215. Elsevier Science, New York.
31. Morell P., Barrett C. V., Mason J. L., Toews A. D., Hostettler J. D., Knapp G. W. and Matsushima G. K. (1998) Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol. Cell. Neurosci. 12, 220-227.
32. Muse E. D., Jurevics H., Toews A. D., Matsushima G. K. and Morell P. (2001) Parameters related to lipid metabolism as markers of myelination in mouse brain. J. Neurochem. 76, 77-86.
33. Nonaka G. and Kishimoto Y. (1979) Simultaneous determination of picomole levels of gluco-and galactosylcerebroside, monogalactosly diglyceride and sulfatides by high performance liquidchromatography. Biochem. Biophys. Acta 572, 423-431.
34. Norton W. T. and Poduslo S. E. (1973) Myelination in rat brain: changes in myelin composition during brain maturation. J. Neurochem. 21, 759-773.
35. Ousley A. H. and Morell P. (1992) Individual molecular species of phosphatidylcholine and phosphatidylethanolamine in myelin turn over at different rates. J. Biol. Chem. 267, 10362-10369.
36. Raine C. S. (1984) Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab. Invest. 50, 608-635.
37. Roach A., Boylan K., Horvath S., Prusiner S. B. and Hood L. E. (1983) Characterization of cloned cDNA representing rat myelin basic protein: absence of expression in brain of shiverer mutant mice. Cell 34, 799-806.
38. Smith M. E. and Benjamins J. (1984) Model systems for study of perturbations of myelin metabolism, in Myelin, 2nd edn (P. Morell eds.), pp. 441-487. Plenum Press, New York.
39. Smith M. E. and Eng L. F. (1965) The turnover of the lipid components of myelin. J. Am. Oil Chem. Soc. 42, 1013-1018.
40. Spady D. K. and Dietschy J. M. (1983) Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat. J. Lipid Res. 24, 303-315.
41. Stahl N., Jurevics H., Morell P., Suzuki K. and Popko B. (1994) Isolation, characterization, and expression of cDNA clones that encode UDP-galactose:ceramide galactosyltransferase. J. Neurosci. Res. 38, 234-242.
42. Stohlman S. A. and Hinton D. R. (2001) Viral induced demyelination. Brain Pathol. 11, 92-106.
43. Suzuki K. and Kikkawa Y. (1969) Status spongiosus of CNS and hepatic changes induced by cuprizone (bis-cyclohexanone oxalyldihydrazone). Am. J. Pathol. 54, 307-325.
44. Toews A. D., Lee S., Popko B. and Morell P. (1990) Tellurium-induced neuropathy: a model for reversible reductions in myelin protein gene expression. J. Neurosci. Res. 26, 501-507.
45. Turley S. D., Andersen J. M. and Dietschy J. M. (1981) Rates of sterol synthesis and uptake in the major organs of the rat in vivo. J. Lipid Res. 22, 551-569.